Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
99,016,334
-
Shares change
-
+3,387,371
-
Total reported value, excl. options
-
$55,690,000
-
Value change
-
-$10,165,671
-
Put/Call ratio
-
808%
-
Number of buys
-
36
-
Number of sells
-
-57
-
Price
-
$0.5626
Significant Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q1 2016
123 filings reported holding OREX - OREXIGEN THERAPEUTICS INC - COM as of Q1 2016.
OREXIGEN THERAPEUTICS INC - COM (OREX) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99,016,334 shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (22,268,399 shares), VANGUARD GROUP INC (7,613,291 shares), FMR LLC (7,412,756 shares), Foresite Capital Management II, LLC (6,462,080 shares), SAMLYN CAPITAL, LLC (6,160,417 shares), BlackRock Fund Advisors (4,581,728 shares), MORGAN STANLEY (4,087,748 shares), FRANKLIN RESOURCES INC (4,086,988 shares), NEA Management Company, LLC (3,709,000 shares), and BlackRock Institutional Trust Company, N.A. (3,129,448 shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.